Flavimonas oryzihabitans bacteremia: Clinical features and microbiological characteristics of isolates
Journal
Clinical Infectious Diseases
Journal Volume
24
Journal Issue
5
Pages
867-873
Date Issued
1997
Author(s)
Abstract
Flavimonas oryzihabitans is rarely reported as a pathogen in humans. Twelve cases of F. oryzihabitans bacteremia were diagnosed at National Taiwan University Hospital over a 3-year period. The clinical features of these patients were analyzed, and antimicrobial susceptibilities and random amplified polymorphic DNA (RAPD) patterns of the 12 isolates were studied. Among these 12 patients, eight (67%) had underlying neoplastic diseases and all acquired F. oryzihabitans bacteremia while hospitalized. The clinical syndromes included primary bacteremia in 5 patients (42%), biliary tract infection in 3 (25%), and peritonitis, subdural empyema, infusion-related bacteremia, and pneumonia in 1 each. Polymicrobial bacteremia or concomitant fungemia was seen in three patients (25%). All the patients survived after antibiotic treatment. All isolates were susceptible to piperacillin, third- generation cephalosporins, aminoglycosides, and quinolones but resistant to cephalothin, cefuroxime, and trimethoprim. Susceptibility to aztreonam was variable (25%). The RAPD patterns differed among the isolates, indicating the epidemiological unrelatedness of these infections. F. oryzihabitans should be included as an etiology of severe nosocomial infection in patients with underlying debilitating diseases.
SDGs
Other Subjects
aminoglycoside antibiotic agent; antibiotic agent; aztreonam; cefalotin; cefoperazone; cefotaxime; ceftazidime; ceftriaxone; cefuroxime; cephalosporin derivative; ciprofloxacin; gentamicin; imipenem; latamoxef; minocycline; netilmicin; ofloxacin; piperacillin; quinoline derived antiinfective agent; trimethoprim; adolescent; adult; antibiotic sensitivity; article; bacteremia; bacterial peritonitis; bacterial pneumonia; bacterium isolation; biliary tract infection; blood culture; child; Chromobacterium; clinical article; clinical feature; female; hospital infection; human; infant; male; priority journal; random amplified polymorphic DNA; subdural empyema; treatment outcome
Type
journal article
